Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis 2016 NIGMS 1P20GM113126-01 5965 In Vitro Liver Models to Investigate the Progression of Liver Fibrosis KIDAMBI, SRIVATSAN UNIVERSITY OF NEBRASKA LINCOLN NE $186,270
Hepatitis 2016 NIGMS 1P20GM113226-01 6168 Administrative Core MCCLAIN, CRAIG UNIVERSITY OF LOUISVILLE KY $669,465
Hepatitis 2016 NIGMS 1P20GM113226-01 6172 Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver disease KIRPICH, IRINA UNIVERSITY OF LOUISVILLE KY $184,680
Hepatitis 2016 NIGMS 1P20GM113226-01 6176 Effects of Dietary Fat on the Hepatotoxicity of Environmental Arsenic WATSON, WALTER UNIVERSITY OF LOUISVILLE KY $184,680
Hepatitis 2016 NIDA 4R25DA013582-15 Clinical Addiction Research and Education Program SAMET, JEFFREY BOSTON MEDICAL CENTER MA $349,453
Hepatitis 2016 NIAAA 1K01AA024174-01 Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease PI, LIYA UNIVERSITY OF FLORIDA FL $145,057
Hepatitis 2016 NIAID 4R01AI095097-05 HIV co-infection and HCV-induced liver fibrosis in vivo SU, LISHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $370,000
Hepatitis 2016 NHLBI 5R01HL119830-02 TTC39B in Metabolism TALL, ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $400,000
Hepatitis 2016 NIAID 5R01AI110577-02 Dynamics of Hepatis C viral RNA-dependent RNA replication JOHNSON, KENNETH UNIVERSITY OF TEXAS, AUSTIN TX $450,062
Hepatitis 2016 NIDA 1DP2DA040244-01 Reaching the hardest of the hard-to-reach SOLOMON, SUNIL JOHNS HOPKINS UNIVERSITY MD $2,430,000
Hepatitis 2016 NIAID 5R01AI114748-02 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Hepatitis 2016 NIAID 5R03AI115171-03 Exploring HCV infection in engineered cultures of iPSC-derived human liver cells KHETANI, SALMAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $79,921
Hepatitis 2016 NIAID 4R01AI103440-04 A molecular basis for control of T cell memory HEDRICK, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $465,000
Hepatitis 2016 NIAID 5R01AI104494-03 A screen for antiviral compounds targeting the Hepatitis B Virus ribonuclease H TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $337,500
Hepatitis 2016 NIAID 4R01AI104887-04 Control of Viral Pathogenesis by Regulation of 2-5A Levels WEISS, SUSAN UNIVERSITY OF PENNSYLVANIA PA $713,295
Hepatitis 2016 NIDA 4R01DA035146-04 HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $608,005
Hepatitis 2016 NIDA 4P30DA011041-19 5121 Infectious Diseases and Biomedical Core PERLMAN, DAVID NEW YORK UNIVERSITY NY $102,568
Hepatitis 2016 NIAID 5UM1AI069418-10 Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit LENNOX, JEFFREY EMORY UNIVERSITY GA $2,052,913
Hepatitis 2016 NIAID 5UM1AI069503-10 Terry Beirn CPCRA Clinical Trials Unit GORDIN, FRED GEORGE WASHINGTON UNIVERSITY DC $5,055,518
Hepatitis 2016 NIAID 5UM1AI068632-10 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $11,550,503
Hepatitis 2016 NICHD 5UM1AI068632-10 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $4,478,297
Hepatitis 2016 NCI 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,100,000
Hepatitis 2016 NIAID 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $29,651,481
Hepatitis 2016 NIDA 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Hepatitis 2016 NINDS 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Hepatitis 2016 OD 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $3,061,000
Hepatitis 2016 NIDDK 5R01DK101941-02 Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients GARG, ABHIMANYU UT SOUTHWESTERN MEDICAL CENTER TX $363,656
Hepatitis 2016 NIAID 5R37AI047365-17 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $458,399
Hepatitis 2016 NIAAA 1P50AA024333-01 8232 Core C: Clinical Core MCCULLOUGH, ARTHUR CLEVELAND CLINIC LERNER COM-CWRU OH $168,149
Hepatitis 2016 NIAAA 1P50AA024333-01 8234 Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury BROWN, JONATHAN CLEVELAND CLINIC LERNER COM-CWRU OH $249,638
Hepatitis 2016 NIAAA 1P50AA024333-01 8237 Project 4: Innate Immunity and Cell Death in ALD NAGY, LAURA CLEVELAND CLINIC LERNER COM-CWRU OH $249,638
Hepatitis 2016 NIAAA 1P50AA024337-01 8302 Role of Dietary Fat in Alcoholic Liver Disease MCCLAIN, CRAIG UNIVERSITY OF LOUISVILLE KY $68,216
Hepatitis 2016 NIAID 4UM1AI069536-10 HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU) SPECTOR, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $2,074,220
Hepatitis 2016 NHLBI 5K01HL121010-03 The Role of CD8+ T Cells In The Development of Nonalcoholic Fatty Liver Disease KENNEDY, ARION VANDERBILT UNIVERSITY TN $113,004
Hepatitis 2016 NIAID 4R01AI050611-12 A chicken model to study hepatitis E virus pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $393,587
Hepatitis 2016 NIDDK 5R01DK074932-10 LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease HUI, DAVID UNIVERSITY OF CINCINNATI OH $355,500
Hepatitis 2016 NIAID 5U01AI115711-02 Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant GRINSPOON, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $685,269
Hepatitis 2016 NIAID 4K08AI102761-04 Mechanisms of Neutralizing Antibody Resistance in Chronic HCV and HIV Infection BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $185,121
Hepatitis 2016 NIDDK 5K08DK099412-02 The role of macrophage migration inhibitory factor in autoimmune hepatitis ASSIS, DAVID YALE UNIVERSITY CT $152,874
Hepatitis 2016 NIAID 5R01AI108765-03 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $435,000
Hepatitis 2016 OD 2R13AI071925-08 Liver Disease and HIV SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $40,000
Hepatitis 2016 NIDDK 5R01DK102597-02 NAFLD: Mechanisms and Treatments TIMCHENKO, NIKOLAI CINCINNATI CHILDRENS HOSP MED CTR OH $351,000
Hepatitis 2016 NIAAA 5P50AA011999-18 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $203,571
Hepatitis 2016 NIAAA 4U01AA021838-04 Transcriptomics of Liver in Alcoholic Hepatitis NORDEN-KRICHMAR, TRINA UNIVERSITY OF CALIFORNIA-IRVINE CA $263,980
Hepatitis 2016 NIAAA 4U01AA021898-04 ALCOHOLIC HEPATITIS PATHOGENESIS AS DETERMINED FROM HUMAN LIVER TISSUE ANALYSIS FRENCH, SAMUEL LA BIOMED RES INST/ HARBOR UCLA MED CTR CA $210,123
Hepatitis 2016 NIAID 4R01AI070101-10 Mechanisms of hepatitis C virus persistence GRAKOUI, ARASH EMORY UNIVERSITY GA $440,000
Hepatitis 2016 NIDDK 5F32DK105845-02 Investigating Synthetic Ligands for the Treatment of NASH GRIFFETT, KRISTINE SAINT LOUIS UNIVERSITY MO $59,970
Hepatitis 2016 NIAID 4R01AI096882-05 Persistent hepatitis C virus replication and T cell immunity in pregnancy WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $584,545
Hepatitis 2016 NIAID 5R01AI099506-03 Modulation of internal ribosome entry by ribosomal protein RPS25 SARNOW, PETER STANFORD UNIVERSITY CA $577,666
Hepatitis 2016 NIAID 5U01AI115714-02 Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant STOCK, PETER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $604,473
Hepatitis 2016 NIAID 5R01AI116639-02 Hepatitis B virus vaccine escape mutants TONG, SHUPING RHODE ISLAND HOSPITAL RI $362,250
Hepatitis 2016 NIDDK 5R01DK099055-03 Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease PARK, IN-WOO UNIVERSITY OF NORTH TEXAS HLTH SCI CTR TX $334,839
Hepatitis 2016 NIDDK 5R01DK077704-08 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $337,125
Hepatitis 2016 NCI 5R01CA193244-06 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $368,367
Hepatitis 2016 NIDDK 4K23DK095707-04 An Assessment of Liver Disease in HIV-infected and HIV/HBV Co-infected Tanzanians HAWKINS, CLAUDIA NORTHWESTERN UNIVERSITY AT CHICAGO IL $126,889
Hepatitis 2016 NIDDK 5R03DK105303-02 Hepatocyte Notch Signaling Regulates NASH PAJVANI, UTPAL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $80,000
Hepatitis 2016 NIAID 5R01AI113923-02 Positive Immune-regulators During Chronic Viral Infections ZUNIGA, ELINA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $464,225
Hepatitis 2016 NIDA 5R34DA038530-02 A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results METSCH, LISA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $319,837
Hepatitis 2016 NIDA 4K23DA031612-05 Supporting Health in Drug Treatment Court for Women with HIV or Hepatitis C MORSE, DIANE UNIVERSITY OF ROCHESTER NY $171,871
Hepatitis 2016 NIAID 4R01AI105035-04 CD4+ T Cells in Acute Versus Chronic HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $435,000
Hepatitis 2016 NCI 5R01CA086978-13 Molecular mechanism of diet-induced carcinogenesis JACOB, SAMSON OHIO STATE UNIVERSITY OH $311,850
Hepatitis 2016 NIDDK 5P30DK097948-02 5072 Biorepository Core FIOCCHI, CLAUDIO CASE WESTERN RESERVE UNIVERSITY OH $221,916
Hepatitis 2016 NIDDK 5F30DK104562-02 Lipid-mediated control of immune responses in hepatitis C virus infection NARAYANAN, SOWMYA UNIVERSITY OF VIRGINIA VA $48,576
Hepatitis 2016 NIAID 5R21AI107252-02 Anti-HBV therapeutics based on rare-cutting targeted endonucleases JEROME, KEITH FRED HUTCHINSON CANCER RESEARCH CENTER WA $228,715
Hepatitis 2016 NIAID 5R01AI111970-03 Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models BROWN, ASHLEY UNIVERSITY OF FLORIDA FL $1,120,190
Hepatitis 2016 NIAID 5R01AI114630-02 Innate Immune Response to Hepatocyte Death CRISPE, IAN UNIVERSITY OF WASHINGTON WA $614,851
Hepatitis 2016 NIAID 4R01AI097318-06 Underlying Mechanisms of ApoE in HCV Infection and Assembly LUO, GUANGXIANG UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $367,500
Hepatitis 2016 NIAID 5R44AI106215-03 Development of a Microfluidic Point-of-Care HCV Viral Load Assay FERNANDEZ-SUAREZ, MARTA DAKTARI DIAGNOSTICS, INC. MA $597,342
Hepatitis 2016 NIAID 5R21AI118337-02 Host and viral determinants of hepatitis C virus macaque infection EVANS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $263,629
Hepatitis 2016 NIDA 4R01DA015612-14 Making Better Decisions: Policy Modeling for AIDS and Drug Abuse OWENS, DOUGLAS STANFORD UNIVERSITY CA $623,455
Hepatitis 2016 NIAID 1K08AI121348-01 Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy MEISSNER, ERIC MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $184,637
Hepatitis 2016 NIAAA 5K23AA023753-02 Understanding and intervening with heavy drinking among patients with HIV and HCV ELLIOTT, JENNIFER NEW YORK STATE PSYCHIATRIC INSTITUTE NY $186,192
Hepatitis 2016 NCI 5R01CA190776-02 A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $636,299
Hepatitis 2016 NIDA 5R01DA027379-05 Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $485,416
Hepatitis 2016 NIAAA 5R21AA022720-02 BMAL1: A Novel Regulator For Inflammatory Liver Injury YIN, LEI UNIVERSITY OF MICHIGAN MI $222,813
Hepatitis 2016 NIDDK 5K08DK101754-03 New Hepatocyte Model Systems to study Hepatitis B Virus Infection SCHWARTZ, ROBERT WEILL MEDICAL COLL OF CORNELL UNIV NY $153,457
Hepatitis 2016 NIAID 5R01AI106005-03 Dissecting virus neutralizing determinants to guide HCV vaccine development LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $450,000
Hepatitis 2016 NCI 5R01CA168912-03 Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines HE, YUKAI GEORGIA REGENTS UNIVERSITY GA $320,588
Hepatitis 2016 NIAID 1R21AI122228-01 The impact of quasi-envelopment on hepatitis virus infection and immunity FENG, ZONGDI RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $186,875
Hepatitis 2016 NICHD 5R01HD075549-03 INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $318,609
Hepatitis 2016 NCI 4R01CA166213-05 Super-infection and virus spread during chronic hepadnaviral infection GUDIMA, SEVERIN UNIVERSITY OF KANSAS MEDICAL CENTER KS $319,945
Hepatitis 2016 NIEHS 4R01ES021375-05 PCBs worsen obesity/metabolic syndrome through 'toxic metabolic endotoxemia' CAVE, MATTHEW UNIVERSITY OF LOUISVILLE KY $337,500
Hepatitis 2016 NIDA 4R01DA012568-18 INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS MEHTA, SHRUTI JOHNS HOPKINS UNIVERSITY MD $1,250,722
Hepatitis 2016 NIDDK 4K23DK090209-05 Gender and hormonal influences on liver fibrosis after transplant for hepatitis C FORDE, KIMBERLY UNIVERSITY OF PENNSYLVANIA PA $182,110
Hepatitis 2016 NIAID 5U19AI109965-03 5820 Novel Nucleic Acid Sensing NLRs and Innate Immunity to Viruses TING, JENNY UNIV OF NORTH CAROLINA CHAPEL HILL NC $416,818
Hepatitis 2016 NIAID 5U19AI109965-03 5821 Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $407,731
Hepatitis 2016 NIAID 5U19AI109965-03 5825 Protein Purification and Biochemistry DUNCAN, JOSEPH UNIV OF NORTH CAROLINA CHAPEL HILL NC $328,213
Hepatitis 2016 NIGMS 4P41GM103314-43 National Resource for Mass Spectrom of Biological Macromolecules CHAIT, BRIAN ROCKEFELLER UNIVERSITY NY $1,619,191
Hepatitis 2016 NICHD 5R01HD041230-12 Prenatal Metabolic Programming of the Offspring DEVASKAR, SHERIN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $316,354
Hepatitis 2016 NHLBI 1R01HL127174-01A1 Canonical & non-canonical regulation of the HDL receptor by PDZK1's PDZ domains KRIEGER, MONTY MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $504,478
Hepatitis 2016 NIDA 5R01DA016065-13 HCV Disease Management in HIV-HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $700,614
Hepatitis 2016 NIAAA 4R01AA012863-16 Mechanisms of Liver Injury by Hepatitis C and Alcohol WEINMAN, STEVEN UNIVERSITY OF KANSAS MEDICAL CENTER KS $516,577
Hepatitis 2016 NIDA 5K01DA036452-03 Social Networks of Youth who Misuse Prescription Opioids and Risk for HIV/HCV AL-TAYYIB, ALIA DENVER HEALTH AND HOSPITAL AUTHORITY CO $151,618
Hepatitis 2016 NIAID 4R01AI100748-05 Lamivudine and its Impact on Perinatal HBV Transmission in HIV/HBV Coinfection BHATTACHARYA, DEBIKA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $386,333
Hepatitis 2016 NIDDK 5R01DK041876-28 Mechanisms of Liver Cell Injury GORES, GREGORY MAYO CLINIC ROCHESTER MN $357,750
Hepatitis 2016 NIAID 1R01AI116868-01A1 Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans RIBEIRO, RUY LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $787,985
Hepatitis 2016 NIDDK 4R01DK097374-04 Subversion of hepatocyte phosphoinositide metabolism by hepatitis C virus TAI, ANDREW UNIVERSITY OF MICHIGAN MI $338,213
Hepatitis 2016 NIAID 2R01AI078881-06 Collaborative Integration of HCV Molecular Virology and Mathematical Modeling UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $544,109
Hepatitis 2016 NIAID 5R01AI110358-02 Mechanisms of HCV Assembly YI, MINKYUNG UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $387,500
Hepatitis 2016 NIDDK 5R01DK102619-02 Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease ZHANG, YANQIAO NORTHEAST OHIO MEDICAL UNIVERSITY OH $341,100
Hepatitis 2016 NCI 4R01CA161694-05 Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse SELL, STEWART WADSWORTH CENTER NY $292,725
Hepatitis 2016 NIDA 5R01DA039072-02 Life Course Investigation of People Who Inject Drugs BOOTH, ROBERT UNIVERSITY OF COLORADO DENVER CO $559,014
Hepatitis 2016 NCI 5R01CA188506-02 Dissection of Pten-regulated signals in hepatopathogenesis FENG, GEN-SHENG UNIVERSITY OF CALIFORNIA SAN DIEGO CA $354,563
Hepatitis 2016 NIDA 4R01DA022177-10 Opioids, HIV/HCV and host cell innate immunity HO, WENZHE TEMPLE UNIV OF THE COMMONWEALTH PA $235,966
Hepatitis 2016 NIDDK 5R01DK104956-02 Molecular Imaging of Liver Fibrosis FUCHS, BRYAN MASSACHUSETTS GENERAL HOSPITAL MA $532,832
Hepatitis 2016 NIDDK 5R01DK100314-02 NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling KOHLI, ROHIT CINCINNATI CHILDRENS HOSP MED CTR OH $451,720
Hepatitis 2016 NIAID 4R01AI099245-05 The PIP2-virus interface and PI 4-kinase: novel biology and validation targets GLENN, JEFFREY STANFORD UNIVERSITY CA $996,649
Hepatitis 2016 NIAID 5U19AI111825-03 7689 Effects of Persistent Innate Immune Activation on Vaccine Efficacy RICE, CHARLES ROCKEFELLER UNIVERSITY NY $644,149
Hepatitis 2016 NIDA 5R01DA025885-08 Sustainable HIV Risk Reduction Strategies for CJ Systems LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $545,835
Hepatitis 2016 NIMH 4K01MH097847-04 An Exercise Intervention to Prevent Interferon-Induced Depression in Hepatitis C RETHORST, CHAD UT SOUTHWESTERN MEDICAL CENTER TX $148,640
Hepatitis 2016 NIDA 5K24DA035684-03 Treatment outcomes and comorbidity in HIV-infected IDU LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $167,171
Hepatitis 2016 NIAAA 2R01AA011576-15A1 Alcohol and Monocyte Signaling SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $376,875
Hepatitis 2016 NCI 4R01CA164029-05 Murine Model of HCV-Associated Human Liver Cancer LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $470,695
Hepatitis 2016 NIAID 5R01AI085087-06 Role of Lipids in Hepatitis C Virus Maturation SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $387,500
Hepatitis 2016 NIAID 5U19AI109662-03 7133 Haploid genetic screen to identify host genes required for RNA virruses GLENN, JEFFREY STANFORD UNIVERSITY CA $424,601
Hepatitis 2016 NIAID 5U19AI109662-03 7134 Computation and Repurposing to identfy antivirals directed against dominant PANDE, VIJAY STANFORD UNIVERSITY CA $742,632
Hepatitis 2016 NIAID 5U19AI109662-03 7135 Novel Interferons and small molecule enhancers of the interferon pathway GARCIA, KENAN STANFORD UNIVERSITY CA $501,177
Hepatitis 2016 NIDA 4K24DA034621-05 Patient Oriented Research in Hepatitis C-infected Injection Drug Users SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $118,638
Hepatitis 2016 NIDDK 5R01DK104735-02 TARGETING THE MITOCHONDRIAL PYRUVATE CARRIER TO TREAT NONALCOHOLIC STEATOHEPATITIS FINCK, BRIAN WASHINGTON UNIVERSITY MO $414,925
Hepatitis 2016 NIDDK 2R01DK081817-06A1 HCV infection, cross-talk among liver cells, and liver disease progression RAY, RATNA SAINT LOUIS UNIVERSITY MO $340,875
Hepatitis 2016 NIAID 5R01AI097552-03 Role of Lipid Droplets in Hepatitis C Virus Infection OTT, MELANIE J. DAVID GLADSTONE INSTITUTES CA $477,500
Hepatitis 2016 NIDA 4R01DA033777-05 Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs MARKOWITZ, MARTIN AARON DIAMOND AIDS RESEARCH CENTER NY $920,449
Hepatitis 2016 NIDA 4R01DA034637-04 Addressing Hepatitis C and Hepatocellular Carcinoma: Current and Future Epidemics HAGAN, HOLLY NEW YORK UNIVERSITY NY $654,934
Hepatitis 2016 NIAID 5U19AI057229-13 7617 The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination DAVIS, MARK STANFORD UNIVERSITY CA $286,356
Hepatitis 2016 NIAID 4R01AI072613-10 Identification and characterization of cellular factors involved in HCV entry RICE, CHARLES ROCKEFELLER UNIVERSITY NY $546,673
Hepatitis 2016 NCI 5R44CA165314-03 A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC) LU, XUANYONG IMCARE BIOTECH PA $657,468
Hepatitis 2016 NCI 5R21CA188472-02 Racial Disparity of microRNA in Hepatitis C Virus Mediated Hepatocellularcarcinoma RAY, RATNA SAINT LOUIS UNIVERSITY MO $177,066
Hepatitis 2016 NCI 5R01CA188305-02 Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis XIAO, HUA MICHIGAN STATE UNIVERSITY MI $339,023
Hepatitis 2016 NIDDK 5R01DK102883-02 HEPATOCYTE REMODELING BY HEPATITIS C VIRUS RANDALL, GLENN UNIVERSITY OF CHICAGO IL $350,489
Hepatitis 2016 NIDDK 4R01DK096076-04 Role of Dab2 in Fatty Liver Disease LEITINGER, NORBERT UNIVERSITY OF VIRGINIA VA $343,650
Hepatitis 2016 NIDDK 4R01DK095862-04 Protective role of adenosine 2A receptor in NAFLD WU, CHAODONG TEXAS A&M AGRILIFE RESEARCH TX $317,242
Hepatitis 2016 NIDDK 1R01DK108357-01 Tissue Responses to Metabolic Stress SCHAFFER, JEAN WASHINGTON UNIVERSITY MO $512,774
Hepatitis 2016 NIAID 4R01AI099284-05 Hepatitis C antivirals: Mechanism of action, combination efficacy and resistance RICE, CHARLES ROCKEFELLER UNIVERSITY NY $735,361
Hepatitis 2016 NCI 4P30AI094189-05 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $74,319
Hepatitis 2016 NHLBI 4P30AI094189-05 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $61,761
Hepatitis 2016 NIA 4P30AI094189-05 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $6,051
Hepatitis 2016 NIAID 4P30AI094189-05 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $300,232
Hepatitis 2016 NICHD 4P30AI094189-05 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $28,115
Hepatitis 2016 NIDA 4P30AI094189-05 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $46,407
Hepatitis 2016 NIMH 4P30AI094189-05 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $53,921
Hepatitis 2016 NIDDK 4R01DK098655-04 Hepatic insulin resistance and metabolic disease WHITE, MORRIS CHILDREN'S HOSPITAL CORPORATION MA $459,892
Hepatitis 2016 NIDDK 5K08DK101757-03 Optimization and control of hepatocyte activity via biofunctional modification WERTHEIM, JASON NORTHWESTERN UNIVERSITY AT CHICAGO IL $151,311
Hepatitis 2016 NIAID 4R01AI052447-14 Gene Silencing as an Antiviral Defense in Animal Cells DING, SHOU-WEI UNIVERSITY OF CALIFORNIA RIVERSIDE CA $493,017
Hepatitis 2016 NIDA 5R25DA037190-03 The Lifespan/Brown Criminal Justice Research Program on Substance Use and HIV BECKWITH, CURT MIRIAM HOSPITAL RI $249,169
Hepatitis 2016 NIDDK 5R01DK101579-04 Physiology of Lipid Droplets and Triglyceride Storage FARESE, ROBERT HARVARD SCHOOL OF PUBLIC HEALTH MA $497,727
Hepatitis 2016 NIDDK 5R01DK101773-02 Innate Defense Program against HCV SAITO, TAKESHI UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis 2016 NIAID 5R03AI111047-02 A High throughput Reverse Genetics System for Hepatitis C Virus FAN, XIAOFENG SAINT LOUIS UNIVERSITY MO $75,750
Hepatitis 2016 NCI 5R01CA186566-02 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $657,227
Hepatitis 2016 NIGMS 4R01GM105414-04 Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV BLACKARD, JASON UNIVERSITY OF CINCINNATI OH $295,229
Hepatitis 2016 NIDA 5R21DA039345-02 Facilitating HCV Treatment through Tailored Prenatal Care for HCV Infected, Substance using Pregnant Women KRANS, ELIZABETH MAGEE-WOMEN'S RES INST AND FOUNDATION PA $194,133
Hepatitis 2016 NIDDK 5R01DK102850-02 Mechanisms underlying Hepatoprotective Roles of Sestrin2 LEE, JUN HEE UNIVERSITY OF MICHIGAN MI $348,750
Hepatitis 2016 NIAID 1R01AI122669-01 Optimization of alpha-hydroxytropolones as novel inhibitors of the HBV RNaseH TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $452,993
Hepatitis 2016 NIDDK 4R01DK095962-04 Novel therapeutic approaches to treating chronic hepatitis B virus infection SU, LISHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $486,852
Hepatitis 2016 NIAID 5R21AI119707-02 Regulation of T cell exhaustion by microRNA-720 HE, YOU-WEN DUKE UNIVERSITY NC $198,750
Hepatitis 2016 NIEHS 5F30ES025099-02 Xenobiotic Receptors Modulate PCB-induced Steatohepatitis CLAIR, HEATHER UNIVERSITY OF LOUISVILLE KY $34,310
Hepatitis 2016 NIAID 1R01AI116943-01A1 A systematic analysis of small RNA interactions during RNA virus infections RICE, CHARLES ROCKEFELLER UNIVERSITY NY $539,134
Hepatitis 2016 NCI 4P01CA022443-39 6854 Mechanisms of Hepatitis B Virus Replication LOEB, DANIEL UNIVERSITY OF WISCONSIN-MADISON WI $322,413
Hepatitis 2016 NCI 4P01CA022443-39 6867 Instrumentation LOEB, DANIEL UNIVERSITY OF WISCONSIN-MADISON WI $68,079
Hepatitis 2016 NCI 4P01CA022443-39 6868 Virus Production MERTZ, JANET UNIVERSITY OF WISCONSIN-MADISON WI $101,042
Hepatitis 2016 NCI 4R01CA089121-10 Hepatitis C Virus and Hepatocellular Carcinoma DASH, SRIKANTA TULANE UNIVERSITY OF LOUISIANA LA $237,038
Hepatitis 2016 NIAID 5K08AI108629-03 Interferon Effector Gene Activation to Circumvent Viral Impedance FUSCO, DAHLENE MASSACHUSETTS GENERAL HOSPITAL MA $186,192
Hepatitis 2016 NIAID 5R01AI116269-02 Immune correlates of acute HBV recovery with and without HIV THIO, CHLOE JOHNS HOPKINS UNIVERSITY MD $666,387
Hepatitis 2016 NIGMS 5SC1GM111158-02 Biological Studies of alpha-Hydroxytropolones MURELLI, RYAN BROOKLYN COLLEGE NY $392,500
Hepatitis 2016 NIAAA 5R21AA023273-02 Translational Bioenergetics in Patients with Alcoholic Liver Disease DARLEY-USMAR, VICTOR UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $174,563
Hepatitis 2016 FIC 5D43TW009771-03 HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis. MANABE, YUKARI JOHNS HOPKINS UNIVERSITY MD $282,804
Hepatitis 2016 NIGMS 4R01GM064803-12 Genome-Scale Analysis of RNA Virus Tertiary Structure WEEKS, KEVIN UNIV OF NORTH CAROLINA CHAPEL HILL NC $317,677
Hepatitis 2016 NIAAA 4U01AA021856-04 Microbiome as Therapeutic Target in Alcoholic Hepatitis SCHNABL, BERND UNIVERSITY OF CALIFORNIA SAN DIEGO CA $427,498
Hepatitis 2016 NIDA 5R01DA033673-05 Implementation of a Sexual Health Intervention for YMSM in Two Vietnamese Cities GOLDSAMT, LLOYD NEW YORK UNIVERSITY NY $492,440
Hepatitis 2016 NIDDK 5R03DK101863-03 TLR4 in Obesity-Driven Liver Fibrosis CAVIGLIA, JORGE COLUMBIA UNIVERSITY HEALTH SCIENCES NY $200,000
Hepatitis 2016 NIDA 4U01DA036267-04 MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) GORBACH, PAMINA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $1,539,723
Hepatitis 2016 NIAAA 4U01AA021912-04 Targeting DAMPs in Alcoholic Hepatitis SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $381,019
Hepatitis 2016 NIDA 5R01DA036514-03 Evaluating a Microfinance Intervention for High Risk Women in Kazakhstan EL-BASSEL, NABILA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $708,767
Hepatitis 2016 OD 5R01OD011095-24 Modeling Viral and T Lymphocyte Dynamics PERELSON, ALAN LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $444,412
Hepatitis 2016 NIDA 1R41DA041246-01 Mobile Intervention Kit to Increase HIV/HCV Testing and Overdose Prevention Training ARONSON, IAN DIGITAL HEALTH EMPOWERMENT, INC. NY $152,762
Hepatitis 2016 NIAID 4R01AI069285-10 Role of TLR3 Signaling in Control of HCV LI, KUI UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $337,500
Hepatitis 2016 NIDA 4R01DA016078-15 The Progression of Hepatitis C Among IDUs with HIV BALAGOPAL, ASHWIN JOHNS HOPKINS UNIVERSITY MD $687,429
Hepatitis 2016 NCI 4R01CA114102-10 The RB pathway in liver cancer SAGE, JULIEN STANFORD UNIVERSITY CA $278,578
Hepatitis 2016 NINR 1F31NR016200-01 Nurse Case Management to Improve Hepatitis C Linkage to Care and Treatment in HIV Coinfection STARBIRD, LAURA JOHNS HOPKINS UNIVERSITY MD $36,091
Hepatitis 2016 NIDA 1R01DA041298-01 Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $594,712
Hepatitis 2016 NIAID 4R01AI079031-08 Understanding human neutralizing antibodies to hepatitis C virus LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $556,005
Hepatitis 2016 NIAID 5U19AI082630-08 7590 Restoration of Innate Immunity with Viral Cure CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $447,514
Hepatitis 2016 NIAID 5U19AI082630-08 7591 Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $466,414
Hepatitis 2016 NIAID 5U19AI082630-08 7592 Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy HAINING, WILLIAM DANA-FARBER CANCER INST MA $533,673
Hepatitis 2016 NIAID 5U19AI082630-08 7593 Induction and Recovery of T Cells after Cure of Chronic Viral Infection KLENERMAN, PAUL UNIVERSITY OF OXFORD UK $321,776
Hepatitis 2016 NIAID 5U19AI082630-08 7594 Administrative Core CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $148,732
Hepatitis 2016 NIAID 5U19AI082630-08 7595 Pilot/Feasibility Studies Program CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $64,620
Hepatitis 2016 NIAID 5U19AI082630-08 7596 Tissue and Clinical Core KIM, ARTHUR MASSACHUSETTS GENERAL HOSPITAL MA $214,234
Hepatitis 2016 NIAID 5U19AI082630-08 7597 Virology Core ALLEN, TODD MASSACHUSETTS GENERAL HOSPITAL MA $80,148
Hepatitis 2016 NCI 5R01CA190678-02 Mechanisms of obesity-induced hepatocarcinogenesis CHUNG, FUNG-LUNG GEORGETOWN UNIVERSITY DC $364,322
Hepatitis 2016 NIDA 5R37DA013806-17 HIV HCV Coinfection Antiviral Therapy and Fibrosis THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $726,240
Hepatitis 2016 NHLBI 5R01HL126543-04 Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms KAPLAN, ROBERT ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $841,929
Hepatitis 2016 NIDDK 4P01DK059820-15 5731 SRC-2 Mediates the Preventative Effects of LRH-1 for NASH in Metabolic Disease MOORE, DAVID BAYLOR COLLEGE OF MEDICINE TX $353,529
Hepatitis 2016 NIDA 4U01DA033336-04 Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry LEE, JOSHUA NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $677,777
Hepatitis 2016 NIDDK 4R01DK100257-04 HBV replication and persistence in mouse models OU, J.-H. JAMES UNIVERSITY OF SOUTHERN CALIFORNIA CA $358,875
Hepatitis 2016 NIGMS 4R01GM081346-08 Structural basis of protein synthesis by the hepatitis C virus IRES RNA KIEFT, JEFFREY UNIVERSITY OF COLORADO DENVER CO $292,989
Hepatitis 2016 NIAAA 4U01AA021908-04 Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis BATALLER, RAMON UNIV OF NORTH CAROLINA CHAPEL HILL NC $1,205,194
Hepatitis 2016 NIAID 5R01AI113267-04 Evaluation of therapeutic benefits of HBV nucleocapsid assembly inhibitors GUO, JU-TAO BARUCH S. BLUMBERG INSTITUTE PA $578,621
Hepatitis 2016 NIAAA 2R24AA012885-16 Integrative Liver Cell Core TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $452,601
Hepatitis 2016 NIMH 5R21MH106904-02 Neurobiology of cytokine effects on CNS glutamate in IFN-alpha-induced depression FELGER, JENNIFER EMORY UNIVERSITY GA $195,000
Hepatitis 2016 NCI 5F32CA192633-02 Disruption of the Host DNA Damage Response by Hepatitis C Virus MITCHELL, JONATHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $32,484
Hepatitis 2016 NIDDK 5R01DK106348-02 In Vivo 2H/13C Metabolic Flux Analysis of NASH Pathogenesis YOUNG, JAMEY VANDERBILT UNIVERSITY TN $347,358
Hepatitis 2016 NIDDK 1R01DK108743-01 Control of stellate cells-driven liver cancer by the p62/NBR1 adapters MOSCAT, JORGE SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $454,727
Hepatitis 2016 NIDDK 2P01DK057751-16 5096 Expression of the type 3 InsP3 receptor in the injured hepatocyte: mechanisms and effects NATHANSON, MICHAEL YALE UNIVERSITY CT $349,685
Hepatitis 2016 NIDDK 4K01DK095031-06 Interactions between type I and III interferon during resolution of HCV infection SCHOGGINS, JOHN UT SOUTHWESTERN MEDICAL CENTER TX $102,087
Hepatitis 2016 NIAID 1R01AI123365-01 Structure and function of Hepacivirus envelope glycoprotein LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $625,625
Hepatitis 2016 NIAAA 4R01AA021133-04 RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse PROESCHOLD-BELL, RAE JEAN DUKE UNIVERSITY NC $690,304
Hepatitis 2016 NIMH 4R01MH085538-07 Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients PULLIAM, LYNN NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $508,271
Hepatitis 2016 NIDA 5R21DA038304-02 Digital Health Technology Use Among Methadone Maintenance Patients MASSON, CARMEN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $184,934
Hepatitis 2016 NIAAA 4U01AA021902-05 Novel Therapies in Alcoholic Hepatitis - UMMS Admin Core SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $41,875
Hepatitis 2016 NIAAA 4U01AA021907-05 Novel Therapies in alcoholic hepatitis - UMMS Translational Program SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $353,929
Hepatitis 2016 NIAID 5K23AI108355-02 Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients VENUTO, CHARLES UNIVERSITY OF ROCHESTER NY $140,233
Hepatitis 2016 NIDDK 5R01DK099226-03 G Protein pathways as Novel Therapeutic and Diagnostic Targets in Liver Fibrosis GHOSH, PRADIPTA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $232,500
Hepatitis 2016 NIDA 1R34DA041465-01 Facilitating treatment entry and family planning in substance-using NICU mothers STOTTS, ANGELA UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $231,000
Hepatitis 2016 NIAAA 4U01AA021893-05 Novel Therapies for Alcoholic Hepatitis MCCULLOUGH, ARTHUR CLEVELAND CLINIC LERNER COM-CWRU OH $1,114,312
Hepatitis 2016 NIAAA 5U01AA021887-06 Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis NIETO, NATALIA UNIVERSITY OF ILLINOIS AT CHICAGO IL $383,520
Hepatitis 2016 NIAAA 4U01AA021901-05 Novel therapies in alcoholic hepatitis University of Louisville MCCLAIN, CRAIG UNIVERSITY OF LOUISVILLE KY $261,000
Hepatitis 2016 NIAAA 4U01AA021890-05 Novel therapeutics for alcoholic hepatitis - Cleveland Translational Component NAGY, LAURA CLEVELAND CLINIC LERNER COM-CWRU OH $273,273
Hepatitis 2016 NIAAA 5U01AA022614-03 The Role of IL-17 in Alcoholic Liver Disease and Cancer KISSELEVA, TATIANA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $353,250
Hepatitis 2016 NIAID 4R01AI074667-08 Mechanism of Hepatitis E Virus Replication and Pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $402,500
Hepatitis 2016 NIAID 1R03AI123689-01 Structural studies of the HBV ribonuclease H TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $75,750
Hepatitis 2016 NIAAA 1R21AA024840-01 Dissection of Glisson's capsule in alcohol induced liver injury ASAHINA, KINJI UNIVERSITY OF SOUTHERN CALIFORNIA CA $237,188
Hepatitis 2016 NIAAA 4R37AA009300-21 Lipid Aldehyde and Ethanol Induced Liver Damage PETERSEN, DENNIS UNIVERSITY OF COLORADO DENVER CO $480,084
Hepatitis 2016 NIAID 5R21AI119433-02 Mechanisms for cccDNA Formation and Persistence SEEGER, CHRISTOPH RESEARCH INST OF FOX CHASE CAN CTR PA $223,125
Hepatitis 2016 NIAID 5R21AI115476-02 T cell responses at the site of infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $217,500
Hepatitis 2016 NIAID 5R21AI113394-02 Hepatitis B virus transcriptional interference and liver cancer-related mutations TONG, SHUPING RHODE ISLAND HOSPITAL RI $241,500
Hepatitis 2016 NIAID 5R21AI119530-02 Dissecting Dengue Virus Permissiveness using a Stem Cell Differentiation System TANG, HENGLI FLORIDA STATE UNIVERSITY FL $221,453
Hepatitis 2016 NIAID 5R21AI120113-02 Bacterial effectors as probes to study (+) RNA virus-host cell biology LINDENBACH, BRETT YALE UNIVERSITY CT $208,125
Hepatitis 2016 NIDA 4R01DA033866-05 Brief intervention for drug-using rural women at high-risk for HIV/HCV TINDALL, MICHELE UNIVERSITY OF KENTUCKY KY $514,704
Hepatitis 2016 NIAID 5R01AI085051-07 Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition SCHIFFER, CELIA UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $523,252
Hepatitis 2016 NIAID 1R21AI124100-01 Defining novel Riplet-activated antiviral innate immune signaling pathways HORNER, STACY DUKE UNIVERSITY NC $238,500
Hepatitis 2016 NIAID 4K24AI108516-04 HIV, HCV, and gender effects on Liver, Bone, and Vascular Health TIEN, PHYLLIS UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $133,956
Hepatitis 2016 NIAID 5R21AI118686-02 Structure-based immunogen design for hepatitis C virus ZHU, JIANG SCRIPPS RESEARCH INSTITUTE CA $240,625
Hepatitis 2016 NIDA 5R01DA037117-03 Injection Risk Networks in Rural Puerto Rico DOMBROWSKI, KIRK UNIVERSITY OF NEBRASKA LINCOLN NE $633,559
Hepatitis 2016 NIAID 1R21AI123718-01 Structure and Function of Hepatitis Delta Virus RNA-Protein Complexes CASEY, JOHN GEORGETOWN UNIVERSITY DC $233,250
Hepatitis 2016 NIAAA 5R01AA013623-14 Effect of Ethanol on Lipid Metabolism YOU, MIN NORTHEAST OHIO MEDICAL UNIVERSITY OH $341,100
Hepatitis 2016 NIAAA 5R01AA021191-03 VDAC in Ethanol and Aldehyde-Induced Mitochondrial Dysfunction LEMASTERS, JOHN MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $336,375
Hepatitis 2016 NIAAA 4U01AA021883-05 Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-ADMIN) CRABB, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $39,000
Hepatitis 2016 NIAAA 4U01AA021840-05 Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU) CRABB, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $862,255
Hepatitis 2016 NIAAA 5U01AA022489-03 Oxidized Metabolites of Linoleic Acid in Alcohol-induced Liver Injury FELDSTEIN, ARIEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $344,657
Hepatitis 2016 NCI 5R01CA163805-06 Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans JUON, HEE-SOON THOMAS JEFFERSON UNIVERSITY PA $330,974
Hepatitis 2016 NIDDK 5R01DK100429-03 Outcome of NASH in Adolescents after Bariatric Surgery vs. Lifestyle Intervention XANTHAKOS, STAVRA CINCINNATI CHILDRENS HOSP MED CTR OH $547,628
Hepatitis 2016 NIAAA 5R01AA017986-07 Heat shock protein 90 in alcoholic liver disease: targeting macrophage function MANDREKAR, PRANOTI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $376,230
Hepatitis 2016 NIAID 4R01AI098126-05 Role of HCV in aberrant APC activation/function HAHN, YOUNG UNIVERSITY OF VIRGINIA VA $392,100
Hepatitis 2016 NIAID 4R01AI108403-04 Antibody-Mediated Suppression of Antiviral Inflammasome Activation COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $442,767
Hepatitis 2016 NIDA 5K24DA037034-03 Mentoring and Empowerment in the Context of HIV Care for At-Risk Populations JOHNSON, MALLORY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $183,707
Hepatitis 2016 NIAID 1R01AI124006-01 Highly Attenuated Vesiculovirus-based Vectors as HBV Therapeutic Vaccines ROBEK, MICHAEL ALBANY MEDICAL COLLEGE NY $414,042
Hepatitis 2016 NIAID 1R21AI119499-01A1 Hepatitis C virus polyprotein processing efficiency regulates infectious virus production TELLINGHUISEN, TIMOTHY SCRIPPS FLORIDA FL $288,000
Hepatitis 2016 NCCIH 5R01AT001576-14 Role of SAMe in Pathogenesis and Treatment of Non-Alcholic Fatty Liver Disease LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $297,230
Hepatitis 2016 NIAID 4R01AI107301-04 Genetic viral and host adaptations to breach species barriers of HCV PLOSS, ALEXANDER PRINCETON UNIVERSITY NJ $402,500
Hepatitis 2016 NIDA 5R01DA034086-06 Intensive Models of HCV Care for Injection Drug Users LITWIN, ALAIN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $690,269
123


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer